Navigation Links
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
Date:5/9/2008

is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also has an in-licensing and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release may be forward- looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: There can be no assurance that the Company will complete cost- effective clinical trials or meet, as anticipated, the development timelines for the drug candidates in its pipeline, including Zerenex and KRX-0401, or that the Company's stock will not be affected by other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Vivakor, Inc. (OTC Bulle...ders of record on December 1, 2009 will receive th...ica, Inc. that was previously approved by Vivakor,...Nevada corporation of which Vivakor owned approxim...record date. The distribution date is still expect...
(Date:12/4/2009)...wire/ -- Stemline Therapeutics, Inc. today announc...R targeting agents, SL-401 and SL-501, in both in... leukemia (CML) have been selected for poster pres...e American Society of Hematology (ASH), to be held...r will be presented by Stemline,s collaborators at...
(Date:12/3/2009)...swire/ -- JourneyLite of Houston, LLC announced ...tients a second surgical option, vertical sleeve ...m that it currently performs. The first sleeve ga...by surgeon partner, Matthew St. Laurent, MD on O...well. ,, The Vertical Sleeve Gastrectomy (also ...
(Date:12/3/2009)...swire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.... update on its European commercial launch of MuGar... debilitating side effect of radiation treatment a...y Access, partner, SpePharm, in six European count...eece and Sweden. Access is conducting pre-marketin...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4
... Claire, Wis. - StrandVision LLC , an online dig...ital signage hardware supplier in Silverdale, Wash...joint marketing agreement. , ,Under the agreement,...ided with a custom login to the Pacific Signage on...hat will help them specify, design and implement d...
...ison, Wis. - If wireless keeps growing at its pre... get their work done, says a wireless channel mana...xander, spoke at a recent Accelerate Madison pro...unications could be a defining feature for corpora...and enhancements increasing, mobility has become t...
...ison, Wis. -- A proposed ban on all human embryon...ate Senate Tuesday, a proposal opposed by many in ...n, known as AB 499, would outlaw not only cloning ... call therapeutic or research cloning, in which an...al subject for the purposes of harvesting stem cel...
Other Biology Technology:Cisco manager touts wireless advantages 2Cloning ban comes before Wisconsin Senate on Tuesday 2Cloning ban comes before Wisconsin Senate on Tuesday 3
(Date:12/2/2009)..., PHILADELPHIA People who smoke their first cigar...er levels of cotinine, a by-product of nicotine wh...moke, regardless of the number of cigarettes smoke... the risk of lung cancer, our results suggest that... especially at risk for lung cancer," said researc...
(Date:12/2/2009)...ILADELPHIA Assurance of a cancer-free status did ...puterized tomography (CT) lung-cancer screening pr...rs wrote in a study published in Cancer Epidemiol...erican Association for Cancer Research. The Decemb...These findings should negate widespread concern in...
(Date:12/2/2009)...Researchers from the University of Georgia College...dual discovery that could open new avenues for tre...vastating single-celled protozoan parasite that co...f whole-genome sequencing, researchers found that ... bacteria: Bacteroides, which are usually found f...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Swine Flu Continues to Wane 62639 1Swine Flu Continues to Wane 62639 2High Risk Women May Often Avoid Using Tamoxifen 62636 1High Risk Women May Often Avoid Using Tamoxifen 62636 2Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 1Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 2Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 3
...ble canaries in the coal mine, well-recognized for...through their presence and abundance in forest lan...bioindicators that the USDA Forest Services Forest...nitors populations of the symbiotic organisms as p...s. , A new report published by the Pacific Nort...
...OR, N.Y. Max Perutz, a pioneer in the field of p...ne of the first to study the molecular structures ...Georgina Ferry, was recently published by Cold Spr... just a scientist, wrote Dr. Richard E. Dickerson ...rotein Science . [H]e was a fine human being with...
...raordinary action of a new cellular therapy came t...ing in a recent study reported in the April issue ... Germany were able to observe the repair action of...od-derived cells capable of developing into adult ... heart tissue and corrected blood flow imbalance w...
Other Biology News:Power of molecular imaging reveals secrets of the heart 2
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human OSCAR Monoclonal Antibody, Unconjugated, Clone 259501 from R&D Systems
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Biology Products: